1. Home
  2. TAYD vs MOLN Comparison

TAYD vs MOLN Comparison

Compare TAYD & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taylor Devices Inc.

TAYD

Taylor Devices Inc.

HOLD

Current Price

$58.88

Market Cap

132.1M

Sector

Industrials

ML Signal

HOLD

Logo Molecular Partners AG

MOLN

Molecular Partners AG

HOLD

Current Price

$4.39

Market Cap

157.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TAYD
MOLN
Founded
1955
2004
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
132.1M
157.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
TAYD
MOLN
Price
$58.88
$4.39
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$3.75
AVG Volume (30 Days)
6.1K
3.5K
Earning Date
01-05-2026
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.72
N/A
Revenue
$44,593,219.00
N/A
Revenue This Year
$10.81
N/A
Revenue Next Year
$8.37
$1,000.00
P/E Ratio
$20.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.50
$3.36
52 Week High
$59.74
$5.91

Technical Indicators

Market Signals
Indicator
TAYD
MOLN
Relative Strength Index (RSI) 74.05 55.40
Support Level $55.32 $3.98
Resistance Level $52.00 $4.40
Average True Range (ATR) 2.34 0.18
MACD 0.93 -0.01
Stochastic Oscillator 92.96 68.12

Price Performance

Historical Comparison
TAYD
MOLN

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: